Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, providing promising developments across several healthcare and industrial applications. With its structural similarity to In a natural way derived human serum albumin, OsrHSA provides a safer, more trustworthy choice for therapeutic